Skip to main content

Tag: Pharma Regulatory News

Bio-Pharma

Pharma – Europe, Canada, S America, MENA and ROW Regulatory News – Sep 2026

Australia TGA Mandates New eCTD AU Module 1 Version 3.2 Format for Prescription Medicine Submissions. On 4 September, 2026, theTherapeutic Goods Administration (TGA) updated its official guidance...

Anvisa regulatory updates, BfArM regulatory updates, Clinical trial regulations, Cofepris drug approval, drug regulatory intelligence, eCTD AU Module 1, eCTD submissions, EDA pharmaceutical regulations, global pharma regulatory updates, Health Canada drug regulations, Pharma Regulatory News, pharmaceutical regulations 2026, pharmaceutical regulatory compliance ​, pharmaceutical regulatory news September 2026, pharmacovigilance regulations, Swissmedic regulatory updates, TGA regulatory updates

Continue reading

Bio-Pharma

Pharma- Asia, S America, MENA, ROW Regulatory News – July 2025

ARGENTINA ANMAT Opens Public Consultation on ICH E20 Guideline for Adaptive Clinical Trials The National Administration of Drugs, Food and Medical Technology (ANMAT) has opened a public consultation...

ANMAT guidelines, CDSCO digital submission, Clinical trial regulations, Drug safety alerts, Global pharmaceutical compliance, GMP extensions, July 2025 updates, Pharma Regulatory News, Regulatory harmonization, TGA compliance

Continue reading

The First Step

Let's talk about how Vistaar can help you